US health officials are reviewing a nearly $600 million contract awarded to Moderna for bird flu vaccines in the final days of the Biden administration. The evaluation is part of a broader effort to reassess spending on mRNA-based vaccines,

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird flu vaccine, Bloomberg News reported on Wednesday, citing sources.

The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for the next flu season